| PERIOD ENDING | 31-Dec-08 | | Total Revenue | 1,861,909 | | Cost of Revenue | 1,182,858 | | | Gross Profit | 679,051 | | | Operating Expenses | | Research Development |
-
| | Selling General and Administrative | 238,857 | | Non Recurring |
-
| | Others |
-
| | | | Total Operating Expenses |
-
| | | | Operating Income or Loss | 440,194 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (6,822) | | Earnings Before Interest And Taxes | 433,372 | | Interest Expense | 49,929 | | Income Before Tax | 383,443 | | Income Tax Expense | 146,667 | | Minority Interest | (1,201) | | | | Net Income From Continuing Ops | 230,888 | | | Non-recurring Events | | Discontinued Operations |
-
| | Extraordinary Items |
-
| | Effect Of Accounting Changes |
-
| | Other Items |
-
| | | | Net Income | 230,888 | | Preferred Stock And Other Adjustments |
-
| | | Net Income Applicable To Common Shares | $230,888 |
|
0.49% Nasdaq 
Income Statement
